Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous esmolol vs lidocaine for hemodynamic response to laryngoscopy/intubation and postoperative nausea/vomiting
IRCT20100102002963N32Phase 3Completed
- Sponsor
- Islamic Azad University, Yazd Branch
- Start
- Jun 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of esmolol and lidocaine in postoperative nausea and vomiting (PONV) and None (2 arms), sponsored by Islamic Azad University, Yazd Branch. Primary endpoints: Hemodynamic variables during laryngoscopy and tracheal intubation and Postoperative nausea and vomiting. Started Jun 2021; status: completed.
02
Drugs
esmolollidocaine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20100102002963N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002963N32.